FHIT Gene: Fragile Histidine Triad Diadenosine Triphosphatase

A tumor suppressor gene frequently altered in cancer, encoding a hydrolase involved in purine metabolism and apoptosis.

Gene Information Card

Symbol FHIT
Full Name Fragile Histidine Triad Diadenosine Triphosphatase
Gene Type Protein coding
Chromosomal Location 3p14.2
NCBI Gene ID 2272 ncbi.nlm.nih.gov/gene/2272
Ensembl ID ENSG00000189283
UniProt ID P49789
OMIM ID 601153
HGNC ID 3701
Aliases AP3Aase, FRA3B, FHIT

Description

The FHIT gene encodes a diadenosine triphosphatase (Ap3A hydrolase) involved in purine nucleotide metabolism. It spans the common fragile site FRA3B on chromosome 3p14.2, making it highly susceptible to deletions and rearrangements in cancer. FHIT functions as a tumor suppressor by regulating apoptosis, cell cycle, and DNA damage response. Loss of FHIT expression is frequently observed in various cancers, including lung, breast, esophageal, and gastric carcinomas.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Lung cancer Loss of FHIT expression due to deletions or promoter methylation leads to reduced apoptosis and increased genomic instability. Multiple studies; COSMIC, ClinVar
Breast cancer FHIT inactivation via loss of heterozygosity (LOH) at 3p14.2 contributes to tumor progression. ClinVar, OMIM
Esophageal squamous cell carcinoma Frequent FHIT deletions and reduced protein expression correlate with poor prognosis. COSMIC, NCBI
Gastric cancer Hypermethylation of FHIT promoter and allelic loss are common. ClinVar, OMIM
Head and neck squamous cell carcinoma FHIT loss associated with advanced stage and metastasis. COSMIC

Expression Profile

Tissue Expression
Tissue nTPM level
Kidney 12.3 Medium
Liver 9.8 Medium
Lung 7.5 Low
Breast 6.2 Low
Esophagus 5.1 Low
Cell Line Expression
Cell Line nTPM Notes
HEK 293 14.5 Embryonic kidney; high expression
HeLa 8.2 Cervical carcinoma; moderate
A549 4.3 Lung carcinoma; low
MCF7 3.9 Breast carcinoma; low
HCT116 6.7 Colorectal carcinoma; moderate
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.1A>G (p.Met1?) Missense <1% Loss of start codon; likely loss of function
c.244C>T (p.Arg82*) Nonsense <1% Premature stop; loss of function
c.340_341del (p.Glu114fs) Frameshift <1% Frameshift; loss of function
Exon 5 deletion Deletion Common in cancer Loss of catalytic domain; loss of function
Mutation functional classification

Loss of Function (LOF)

Most FHIT mutations (nonsense, frameshift, deletions) result in loss of hydrolase activity and tumor suppressor function.

Gain of Function (GOF)

No gain-of-function mutations reported.

Dominant Negative (DN)

No dominant-negative mutations reported.

Gene Ontology (GO)

• diadenosine triphosphatase activity (GO:0003996) protein binding (GO:0005515)
cytoplasm (GO:0005737) cytosol (GO:0005829)
apoptotic process (GO:0006915) • cell cycle (GO:0007049)
nucleotide catabolic process (GO:0009166)

Pathways

Purine metabolism (KEGG: hsa00230)
Apoptosis (Reactome: R-HSA-109581)

Protein Summary

FHIT is a 147-amino acid protein (17 kDa) that hydrolyzes diadenosine triphosphate (Ap3A) to AMP and ADP. It is predominantly cytoplasmic and plays a role in apoptosis and cell cycle regulation. Loss of FHIT protein expression is a hallmark of many cancers, often due to genomic deletions at the FRA3B fragile site.

Related Products

Product name Cat.No. Species Gene ID
FHIT Knockout HEK293 Cell Line EDJ-KQ2877 Human 2272 Details Get a Quote
FHIT Knockout HCT 116 Cell Line EDJ-KQ23922 Human 2272 Details Get a Quote
FHIT Knockout HeLa Cell Line EDJ-KQ23923 Human 2272 Details Get a Quote
FHIT Knockout A-549 Cell Line EDJ-KQ61715 Human 2272 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: